These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22425169)

  • 1. Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol.
    Shirts BH; Howard MT; Hasstedt SJ; Nanjee MN; Knight S; Carlquist JF; Anderson JL; Hopkins PN; Hunt SC
    Atherosclerosis; 2012 May; 222(1):167-74. PubMed ID: 22425169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOA5 genotype influences the association between 25-hydroxyvitamin D and high density lipoprotein cholesterol.
    Vimaleswaran KS; Cavadino A; Hyppönen E
    Atherosclerosis; 2013 May; 228(1):188-92. PubMed ID: 23452379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
    Yin RX; Li YY; Lai CQ
    Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
    Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
    Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of polymorphisms in APOA4-APOA5-ZPR1-BUD13 gene cluster and sleep duration on 5-year lipid changes in middle aged and older Chinese.
    Yang L; Ma L; Guo W; Fang Q; Lai X; Zhang X
    Sleep; 2019 Aug; 42(8):. PubMed ID: 31181149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D concentrations on metabolic and cardiovascular disease outcomes.
    Vimaleswaran KS; Power C; Hyppönen E
    Diabetes Metab; 2014 Nov; 40(5):386-9. PubMed ID: 24582179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women.
    Saadi HF; Nagelkerke N; Benedict S; Qazaq HS; Zilahi E; Mohamadiyeh MK; Al-Suhaili AI
    Bone; 2006 Nov; 39(5):1136-1143. PubMed ID: 16814623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
    Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
    Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.
    Laurila PP; Naukkarinen J; Kristiansson K; Ripatti S; Kauttu T; Silander K; Salomaa V; Perola M; Karhunen PJ; Barter PJ; Ehnholm C; Peltonen L
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):346-52. PubMed ID: 19910639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
    Brautbar A; Covarrubias D; Belmont J; Lara-Garduno F; Virani SS; Jones PH; Leal SM; Ballantyne CM
    Atherosclerosis; 2011 Dec; 219(2):737-42. PubMed ID: 21889769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of common genetic variants in the APOA5, LPL and GCK genes with longitudinal changes in metabolic and cardiovascular traits.
    Webster RJ; Warrington NM; Weedon MN; Hattersley AT; McCaskie PA; Beilby JP; Palmer LJ; Frayling TM
    Diabetologia; 2009 Jan; 52(1):106-14. PubMed ID: 19018513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
    Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
    PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region.
    OʼBrien SE; Schrodi SJ; Ye Z; Brilliant MH; Virani SS; Brautbar A
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):183-8. PubMed ID: 25900265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
    Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
    Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin.
    Smith CE; Tucker KL; Lai CQ; Parnell LD; Lee YC; Ordovás JM
    Obesity (Silver Spring); 2010 Feb; 18(2):327-32. PubMed ID: 19629056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
    Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
    Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of age and gender on the genetic regulation of serum 25-hydroxyvitamin D - the FIN-D2D population-based study.
    Miettinen ME; Smart MC; Kinnunen L; Keinänen-Kiukaanniemi S; Moilanen L; Puolijoki H; Saltevo J; Oksa H; Hitman GA; Tuomilehto J; Peltonen M
    J Steroid Biochem Mol Biol; 2018 Apr; 178():229-233. PubMed ID: 29287921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
    Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
    Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.